InfuSystem Holdings, Inc (INFU): Capital Expenditures
$560.0K
Year ended 2025-12-31
$460.0K
Trailing 12 months to 2026-06-30
-17.1%
3-year compound annual growth
-12.5%
5-year compound annual growth
+6.0%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $560.0K | -48.7% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $1.09M | +6.6% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $1.02M | +4.3% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $982.0K | +0.2% | 2024-04-10, From 2022-01-01 |
| 2021-12-31 | $980.0K | -10.4% | 2024-04-10, From 2021-01-01 |
| 2020-12-31 | $1.09M | -62.6% | 2023-03-16, From 2020-01-01 |
| 2019-12-31 | $2.93M | +941.3% | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $281.0K | +170.2% | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | $104.0K | -38.1% | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $168.0K | -46.5% | 2018-03-19, From 2016-01-01 |
| 2015-12-31 | $314.0K | -84.3% | 2017-03-22, From 2015-01-01 |
| 2014-12-31 | $2.00M | -57.8% | 2016-12-12, From 2014-01-01 |
| 2013-12-31 | $4.72M | n/a | 2015-03-09, From 2013-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $560.0K | -48.7% |
| Neuronetics, Inc. (STIM) | 2025-12-31 | $801.0K | -45.4% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $2.38M | -42.1% |
| Heartflow, Inc. (HTFL) | 2025-12-31 | $5.03M | +15.3% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $4.20M | +10.5% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $6.83M | -11.7% |
| SI-BONE, Inc. (SIBN) | 2025-12-31 | $8.41M | -19.8% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $5.30M | +56.0% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $332.0K | +8.5% |
Compare INFU, STIM, XTNT, HTFL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗